The ESMO Tumour Portals allow you to find the key educational resources in your field of interest
ESMO members: Browse through the ESMO Glossary of Molecular Biology in Cancer online
ESMO E-Learning platform now has a new look and improved features. V-Learning modules include educational videos. Available on all browsers and mobile devices!
21 Jul 2014
Positive trial results for siltuximab in the treatment of multicentric Castleman’s disease
21 Jul 2014
R.Coleman explains how the trial results can help plan treatment for women with metastatic breast cancer, highlighting advantages of a less intensified approach.
18 Jul 2014
Antibody therapy against the programmed-death-receptor-1 may help patients with advanced melanoma progression after ipilimumab and other targeted...
17 Jul 2014
Prophylactic mastectomy provides only a “very modest” survival benefit for women at average risk of contralateral primary breast cancer
R.Coleman explains how the trial results can help plan treatment for women with metastatic breast cancer, highlighting advantages of a less intensified approach. The study was requested by regulatory bodies, originally with placebo in the comparator arm. Due to failed recruitment, the study design was changed. Further trials on bisphosphonates duration are no longer needed.